ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction

OBJECTIVES: Anoctamin 1 (ANO1) has been found to be overexpressed in esophageal squamous cell carcinoma (ESCC) in our previous study. Herein we showed the clinical relevance of ANO1 alterations with ESCC and esophageal precancerous lesion progression. RESULTS: ANO1 was detected in 38.1% (109/286) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Li, Hao, Jia-Jie, Zhao, Xue-Ke, He, Jian-Zhong, Shi, Zhi-Zhou, Liu, Hui-Juan, Wu, Li-Fei, Jiang, Yan-Yi, Shi, Feng, Yang, Hai, Zhang, Yu, Liu, Yi-Zhen, Zhang, Tong-Tong, Xu, Xin, Cai, Yan, Jia, Xue-Mei, Li, Min, Zhan, Qi-Min, Li, En-Min, Wang, Li-Dong, Wei, Wen-Qiang, Wang, Ming-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029708/
https://www.ncbi.nlm.nih.gov/pubmed/27016410
http://dx.doi.org/10.18632/oncotarget.8223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029708/
https://www.ncbi.nlm.nih.gov/pubmed/27016410
http://dx.doi.org/10.18632/oncotarget.8223

Ejemplares similares